Cornerstone Pharmaceuticals

Cornerstone Pharmaceuticals

Verified
Cornerstone is committed to developing therapies for rare cancers.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$24—37m (Dealroom.co estimates Jan 2010.)
Cranbury Township New Jersey (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
N/A

$0.0

round
investor

$0.0

round
N/A

$0.0

round
N/A

$0.0

round

N/A

Grant
Total Funding000k

Recent News about Cornerstone Pharmaceuticals

Edit